First drugs facing Medicare price penalty are named

15 March 2023 - US lists 27 medications whose prices rose faster than inflation, triggering rebates under new law. ...

Read more →

Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs

16 March 2023 - Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President ...

Read more →

BMS, Pfizer, AbbVie drugs likely to face US price negotiation

13 March 2023 - The blood thinner Eliquis from BMS, Pfizer's breast cancer drug Ibrance and AbbVie's leukaemia treatment Imbruvica ...

Read more →

Medicare doesn’t pay for obesity drugs: lifting this coverage prohibition faces considerable hurdles

11 March 2023 - A number of different stakeholders across the healthcare landscape are lobbying legislators and the Centers for Medicare ...

Read more →

Medicare Part D coverage of anti-obesity medications — challenges and uncertainty ahead

11 March 2023 - Obesity is highly prevalent in the United States — affecting more than 41% of adults, including a ...

Read more →

Biden calls for tax on the wealthy to extend Medicare funding

8 March 2023 - President Joe Biden this week called for higher taxes on wealthy Americans to extend Medicare funding as ...

Read more →

Drugs likely subject to Medicare negotiation (2026-2028)

28 February 2023 - In 2026-2028, we estimate that Medicare will negotiate prices for 38 Medicare Part D drugs and 2 ...

Read more →

US Medicare says no change to Alzheimer's drug restrictions

23 February 2023 - The US Government health plan for people over the age of 65 on Wednesday said it ...

Read more →

Medicare annual statistics – rolling 12 months (July 2009 to December 2022)

20 February 2023 - This document presents rolling 12 month Medicare statistics by three variables ...

Read more →

Senators call on Medicare to offer broad coverage of Alzheimer’s treatments as public pressure grows

17 February 2023 - A group of 20 senators called on Medicare to take action now to offer seniors immediate access ...

Read more →

US to select 10 costliest drugs for Medicare pricing negotiation

18 February 2023 - The US Government will select the 10 costliest prescription medicines to Medicare for negotiating prices with ...

Read more →

Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

17 February 2023 - Eisai anticipates about 100,000 patients diagnosed will be eligible for the drug by year three of its ...

Read more →

HHS releases initial guidance for Medicare prescription drug inflation rebate program

9 February 2023 - Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for ...

Read more →

Miracle’ cystic fibrosis drug kept out of reach in developing countries

7 February 2023 - Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients ...

Read more →

Release of the Strengthening Medicare Taskforce Report

3 February 2023 - The Strengthening Medicare Taskforce Report is now available.  ...

Read more →